AGP Picks
View all

North Dakota Healthcare Newswire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Dakota Healthcare Newswire.

Press releases published on November 12, 2026

Serotonin Anti-Aging Centers Founder Puts a Physician-Led Longevity Clinic Inside New York Sports Club
Aristocrat Plastic Surgery Expands Access to Preservé Breast Augmentation Under Trainer Dr. Kevin Tehrani, Who Has Performed More Than 5,000 Breast Procedures, Reinforcing Its Position as a Destination for Breast Augmentation in NYC
Cyclarity Therapeutics Receives FDA Investigational New Drug Clearance for UDP-003 to expand Atherosclerosis Clinical Development Program into the United States
HealthPRO Canada Earns Great Place to Work® Certification for Fifth Consecutive Year
How Clinical Trials Really Work: Understanding the 4 Phases
SimpliFed Appoints Gemma Wenstrom as Chief Operations Officer
MIRACLE FLIGHTS EXPANDS FINANCIAL ELIGIBILITY TO HELP MORE CHILDREN ACCESS CRITICAL MEDICAL CARE NATIONWIDE
Istios Health Expands Clinical Research Network into Arkansas Through Arkansas Renal Group Partnership
Ennature Biopharma Advances Curcumin Formulation With Water-Dispersible Maxicuma
QUAD A Announces Dr. Monte Jay Goldstein as President of Its Board of Directors 
Lungpacer Medical Announces First Patient Enrollment in AERO-PAS Post-Approval Study of the AeroPace® System
National Advertising Division Recommended IQ BAR Discontinue “Superior Brain and Body Nutrition” Claim
Patients Know Best Launches in Australia through Consultmed partnership
Pharvaris Presents Clinical and Real-World Data at the ACAAI 2026 Annual Scientific Meeting
High Point University Prepares to Open North Carolina’s First School of Optometry
NeOnc CEO Buys More Shares Below $5 as NTHI Secures FDA Meeting to Discuss Phase 3 Trial
NYC Mommy Makeover Center Supports Local Moms as Mommy Makeover Interest Jumps 60%
American Urological Association Announces Incoming Editor of JU Open Plus
Aravax Announces Positive Results of Phase 2 Clinical Trial of PVX108, a Novel Immunotherapy for the Treatment of Peanut Allergy
DBV Technologies Highlights New Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

North Dakota Healthcare Newswire

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.